“The Iran-made vaccine produced by our colleagues at the Headquarters has successfully passed the animal tests and now we are preparing for tests on humans after receiving license from the health ministry,” Mokhber told reporters on Wednesday.
He also said that Remdesivir - a drug believed to be of help in fighting the coronavirus – has been produced by the Headquarters at a lower price than its foreign version and distributed in the market and will be mass-produced upon a request of the Iranian health ministry.
Iranian Health Minister Saeed Namaki had announced in June that the country's scientists have successfully tested the home-made anti-COVID-19 virus vaccine on animals.
"We have taken effective steps in producing vaccine and many Iranian scientists have taken rapid steps in developing COVID-19 vaccine and the Iranian coronavirus vaccine test samples on animals have proved successful," Namaki said.
He, meantime, underlined the need for global unity and cooperation in the production of vaccines and medicine in campaign against the novel coronavirus.
Also, last Sunday, Namaki said the Remdesivir produced by Iranian researchers has been distributed at medical centers, and added that the medicine will enter the market as of next week.
Namaki noted that another coronavirus-related medicine, Favipiravir, has also entered Iran’s pharmaceutical market.
He emphasized that these medicines are distributed at hospitals only by specialists.